Literature DB >> 13983000

Antibody elution from red blood cells.

H RUBIN.   

Abstract

An elution technique is described which gives eluates at least as potent as previously described methods. Elution can be completed in only 15 minutes. The method, a modification of that of Vos and Kelsall, is simple to carry out and requires the minimum of equipment. Studies have shown that the coating antibody is almost, but not completely, eluted.

Keywords:  ANTIBODIES

Mesh:

Substances:

Year:  1963        PMID: 13983000      PMCID: PMC480489          DOI: 10.1136/jcp.16.1.70

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Elution of incomplete antibodies from red cells: a comparison of different methods.

Authors:  K G JENSEN
Journal:  Vox Sang       Date:  1959-07       Impact factor: 2.144

2.  Eluting red-cell antibodies: a method and its application.

Authors:  W WEINER
Journal:  Br J Haematol       Date:  1957-07       Impact factor: 6.998

3.  A method for eluting antibodies from red cell stromata.

Authors:  T J GREENWALT
Journal:  J Lab Clin Med       Date:  1956-10

4.  A new elution technique for the preparation of specific immune anti-Rh serum.

Authors:  G A KELSALL; G H VOS
Journal:  Br J Haematol       Date:  1956-10       Impact factor: 6.998

5.  Studies on antibodies eluted from the red cells in autoimmune hemolytic anemia.

Authors:  Z D KOMNINOS; M C ROSENTHAL
Journal:  J Lab Clin Med       Date:  1953-06

6.  Elution of an Incomplete Type of Antibody from the Erythrocytes in Acquired Haemolytic Anaemia.

Authors:  P Kidd
Journal:  J Clin Pathol       Date:  1949-05       Impact factor: 3.411

  6 in total
  31 in total

1.  The anti-erythrocyte autoimmune response of NZB mice. Identification of two distinct autoantigens.

Authors:  N A Diiulio; R L Fairchild; M J Caulfield
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Identification of autoantigens in canine autoimmune haemolytic anaemia.

Authors:  R N Barker; T J Gruffydd-Jones; C R Stokes; C J Elson
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  The Dantu erythrocyte phenotype of the NE variety. II. Serology, immunochemistry, genetics, and frequency.

Authors:  P Unger; J L Procter; J J Moulds; M Moulds; D Blanchard; M L Guizzo; L A McCall; J P Cartron; W Dahr
Journal:  Blut       Date:  1987-07

4.  Haematological features of angioimmunoblastic lymphadenopathy with dysproteinaemia.

Authors:  R L Brearley; J Chapman; M H Cullen; M A Horton; A G Stansfeld; A H Waters
Journal:  J Clin Pathol       Date:  1979-04       Impact factor: 3.411

5.  T-cell specificity in murine autoimmune haemolytic anaemia induced by rat red blood cells.

Authors:  R N Barker; C-R Shen; C J Elson
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

6.  Familial thrombocytopenia associated with platelet autoantibodies and chromosome breakage.

Authors:  F M Helmerhorst; D C Heaton; P E Crossen; A E von dem Borne; C P Engelfriet; A T Natarajan
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Evidence of platelet complement-fixing and lymphocytotoxic anti-A-1 antibodies.

Authors:  W Gross; D Heinrich; P Walker; K Mersch-Baumert; C Mueller-Eckhardt
Journal:  Blut       Date:  1975-02

8.  Identification of murine erythrocyte autoantigens and cross-reactive rat antigens.

Authors:  R N Barker; K M Casswell; C J Elson
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Nature and incidence of erythrocyte-bound IgG and some aspects of the physiopathogenesis of anaemia in American visceral leishmaniasis.

Authors:  L C Pontes De Carvalho; R Badaró; E M Carvalho; J Lannes-Vieira; L Vinhaes; G Orge; M C Marsochi; B Galvão-Castro
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

10.  Fixation of the first component of complement (C'la) by human antibodies.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.